共 14 条
[1]
In vitro activity of Bay 12-8039:a new methoxyquinolone against mycobacteria. Gross WM.,Vadeny Fs,Ladutko L,Bonato D A,Campbell S. 37th interscience conference of Antimicrobial Agents and Chenmotherapy . 1997
[2]
In vitro activity of BAY 1208039,a new 8-methoxyquinolone. Pass RJ. Antimicrobial Agents and Chemotherapy . 1997
[3]
Anti-tuberculosis drug resistance in the world. World Health Organization. http://www.who.int/gtb/publications/dritw/ . 1997
[4]
The synthesisand biological properties of 6 - fluoro- quinolinecarboxylicacids. Petersen U,Bartel S,Bermm KD,et al. Bulletin des Societes Chimiques Belges . 1996
[5]
Cycloaracylierung von Enaminen,I.Synthese von 4-Chinolon-3-carbonsauren. Grobe K,Heitzer H,Wiss H,et al. Liebigs Annder Chem . 1987
[6]
Global epidemiology of tuberculosis:morbidity and morbidity of a worldwide epidemic. Raviglione MC,SriiderDE,KochiA. The Journal of The American Medical Association . 1995
[7]
The importance of the cycloaracylation process for the synthesis of modern fluoroguinolones. Grohe.K. Journal für praktische Chemie . 1993
[8]
Comparison of the antibacterial activity of the guinolones BAY 12-8039,gatifloxacin (AM-1155),trovafloxacin, clinafloxacin,levofloxacin and ciprofloxacin. auernfeind A. Journal of Antimicrobial Chemotherapy . 1997
[9]
In vitro activity of BAY12-8039, a new 8-methoxyquinolone. Dalhoff A,Petersen U,Endermann R. Journal of Chemotherapy . 1996
[10]
Maslo C,Truffot-Pernot C.Bonnafous P.Grosset J In vitro and in vivo activities of moxifloxacin and clinafloxacin against My cobacterium tuberculosisi. JIB,Lounis N. Antimicrobial Agents and Chemotherapy . 1998